ZS Pharma Inc stock trades on the US exchange.

Trading Profile: ZS Pharma, Inc., a development stage biopharmaceutical company, focuses on the development and commercialization of non-absorbed drugs to treat renal, cardiovascular, liver, and metabolic diseases. The company’s proprietary zirconium silicate technology creates ion traps that could reduce toxic levels of specific electrolytes without disturbing the balance of other electrolytes. It is developing ZS-9, insoluble non-absorbed zirconium silicate that is in Phase III development for the treatment of hyperkalemia. The company was founded in 2008 and is headquartered in Coppell, Texas.

»»» Detailed Company Profile & Chart

 ZS Pharma Inc current day financials: 2024-04-26 02:45:51pm
Symbol Name Purchase price Last Price Change % Change
0.00
ZS Pharma Inc historical financials from '16
Volume
0
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-4.74
Market Cap (USD)
-
Shares Outstanding (m)
25.269
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Recent ZSPH News from Yahoo Finance & Seeking Alpha

Older Archived News ZS Pharma Inc

  • ZS Pharma (ZSPH) Stock Gets Rating Downgrade at Credit Suisse.
  • Stocks Are Lower as Chances of December Hike Grow.
  • ZS Pharma (ZSPH) Stock Skyrockets on AstraZeneca Merger.
  • Market Isn’t Sure What to Make of Blowout Jobs Report.
  • Stock Futures Struggle for Direction After Blowout Jobs.
  • ZS PHARMA, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with AstraZeneca PLC.
  • ZS PHARMA, INC. Financials.
  • ZS PHARMA, INC. Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failur.
  • ZS Pharma Inc.
  • ZS Pharma Announces New Employment Inducement Grants.
    • Load More News...